121 related articles for article (PubMed ID: 8362830)
1. Long-term Helicobacter pylori recurrence after successful eradication with triple therapy.
Cutler AF; Schubert TT
Am J Gastroenterol; 1993 Sep; 88(9):1359-61. PubMed ID: 8362830
[TBL] [Abstract][Full Text] [Related]
2. Patient factors affecting Helicobacter pylori eradication with triple therapy.
Cutler AF; Schubert TT
Am J Gastroenterol; 1993 Apr; 88(4):505-9. PubMed ID: 8470629
[TBL] [Abstract][Full Text] [Related]
3. Helicobacter pylori recurrence after successful eradication: 5-year follow-up in the United States.
Abu-Mahfouz MZ; Prasad VM; Santogade P; Cutler AF
Am J Gastroenterol; 1997 Nov; 92(11):2025-8. PubMed ID: 9362184
[TBL] [Abstract][Full Text] [Related]
4. Anti-Helicobacter pylori treatment in bleeding ulcers: randomized controlled trial comparing 2-day versus 7-day bismuth quadruple therapy.
Kung NN; Sung JJ; Yuen NW; Ng PW; Wong KC; Chung EC; Lim BH; Choi CH; Li TH; Ma HC; Kwok SP
Am J Gastroenterol; 1997 Mar; 92(3):438-41. PubMed ID: 9068464
[TBL] [Abstract][Full Text] [Related]
5. Randomized comparison of ranitidine bismuth citrate-based triple therapies for Helicobacter pylori.
Laine L; Estrada R; Trujillo M; Emami S
Am J Gastroenterol; 1997 Dec; 92(12):2213-5. PubMed ID: 9399755
[TBL] [Abstract][Full Text] [Related]
6. [Comparison of the efficacy of omeprazole/bismuth subcitrate or triple therapy in Helicobacter pylori gastritis. A prospective controlled study].
Bertschinger P; Brunner J; Flury R; Lammer F; Jost R; Häcki WH
Schweiz Med Wochenschr; 1992 Sep; 122(39):1446-51. PubMed ID: 1411403
[TBL] [Abstract][Full Text] [Related]
7. One-week ranitidine bismuth citrate versus colloidal bismuth subcitrate-based anti-Helicobacter triple therapy: a prospective randomized controlled trial.
Kung NN; Sung JJ; Yuen NW; Li TH; Ng PW; Lai WM; Lui YH; Lam KN; Choi CH; Leung EM
Am J Gastroenterol; 1999 Mar; 94(3):721-4. PubMed ID: 10086657
[TBL] [Abstract][Full Text] [Related]
8. The long-term reinfection rate and the course of duodenal ulcer disease after eradication of Helicobacter pylori in a developing country.
Rollan A; Giancaspero R; Fuster F; Acevedo C; Figueroa C; Hola K; Schulz M; Duarte I
Am J Gastroenterol; 2000 Jan; 95(1):50-6. PubMed ID: 10638558
[TBL] [Abstract][Full Text] [Related]
9. Recurrence of Helicobacter pylori infection after several eradication therapies: long-term follow-up of 1000 patients.
Gisbert JP; Luna M; Gómez B; Herrerías JM; Monés J; Castro-Fernández M; Sánchez-Pobre P; Cosme A; Olivares D; Pajares JM
Aliment Pharmacol Ther; 2006 Mar; 23(6):713-9. PubMed ID: 16556172
[TBL] [Abstract][Full Text] [Related]
10. [Oral triple therapy for eradication of Helicobacter pylori in duodenal ulcer disease].
Labenz J; Gyenes E; Rühl GH; Börsch G
Med Klin (Munich); 1993 May; 88(5):297-9. PubMed ID: 8326916
[TBL] [Abstract][Full Text] [Related]
11. One-day quadruple therapy compared with 7-day triple therapy for Helicobacter pylori infection.
Lara LF; Cisneros G; Gurney M; Van Ness M; Jarjoura D; Moauro B; Polen A; Rutecki G; Whittier F
Arch Intern Med; 2003 Sep; 163(17):2079-84. PubMed ID: 14504122
[TBL] [Abstract][Full Text] [Related]
12. [Effectiveness of triple therapy to eradicate H. pylori in patients after failed therapy with omeprazole/amoxicillin].
Zala G; Schwery S; Giezendanner S; Flury R; Wüst J; Meyenberger C; Wirth HP
Schweiz Med Wochenschr; 1996 Feb; 126(5):153-8. PubMed ID: 8685685
[TBL] [Abstract][Full Text] [Related]
13. [Helicobacter pylori and digestive hemorrhage due to duodenal ulcer: the prevalence of the infection, the efficacy of 3 triple therapies and the role of eradication in preventing a hemorrhagic recurrence].
Gisbert JP; Boixeda D; Aller R; de la Serna C; Sanz E; Martín de Argila C; Abraira V; García Plaza A
Med Clin (Barc); 1999 Feb; 112(5):161-5. PubMed ID: 10091208
[TBL] [Abstract][Full Text] [Related]
14. Prevalence of H. pylori-infection in family members of H. pylori positive and its influence on the reinfection rate after successful eradication therapy: a two-year follow-up.
Knippig C; Arand F; Leodolter A; Nilius M; Bayerdörffer E; Klein U; Malfertheiner P
Z Gastroenterol; 2002 Jun; 40(6):383-7. PubMed ID: 12055660
[TBL] [Abstract][Full Text] [Related]
15. [Breath test in the diagnosis of Helicobacter pylori infection: concordance with histological methods and correlation with anatomopathological lesions of the gastric mucosa].
Gisbert JP; Boixeda D; Redondo C; Alvarez Baleriola I; Jiménez I; Pérez García JI; Pajares JM
Rev Esp Enferm Dig; 1996 Apr; 88(4):259-64. PubMed ID: 9004796
[TBL] [Abstract][Full Text] [Related]
16. Long-term follow-up of Helicobacter pylori treatment in non-ulcer dyspepsia patients.
Elta GH; Scheiman JM; Barnett JL; Nostrant TT; Behler EM; Crause I; Appelman HD
Am J Gastroenterol; 1995 Jul; 90(7):1089-93. PubMed ID: 7611203
[TBL] [Abstract][Full Text] [Related]
17. An audit of low dose triple therapy for eradication of Helicobacter pylori.
Fraser AG; Moore L; Ali MR; Chua LE; Hollis B; Little SV
N Z Med J; 1996 Aug; 109(1027):290-2. PubMed ID: 8773671
[TBL] [Abstract][Full Text] [Related]
18. Long-term follow-up of Helicobacter pylori serology after successful eradication.
Cutler AF; Prasad VM
Am J Gastroenterol; 1996 Jan; 91(1):85-8. PubMed ID: 8561150
[TBL] [Abstract][Full Text] [Related]
19. A single drug for Helicobacter pylori infection: first results with a new bismuth triple monocapsule.
de Boer WA; van Etten RJ; Schneeberger PM; Tytgat GN
Am J Gastroenterol; 2000 Mar; 95(3):641-5. PubMed ID: 10710051
[TBL] [Abstract][Full Text] [Related]
20. The effect of intragastric acidity on Helicobacter pylori eradication with bismuth-metronidazole-amoxicillin.
Chang CS; Yang CY; Wong FN; Chen GH; Lien HC; Yeh HZ; Poon SK
Hepatogastroenterology; 1999; 46(28):2713-7. PubMed ID: 10522070
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
